Oncology Information Systems Market Size Is Estimated To Value $3.4 Billion By 2026 | Players Are Cerner Corporation, RaySearch Laboratories and Flatiron.

The global oncology information systems market size is expected to reach USD 3.4 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 8.4% during the forecast period. Increasing prevalence of cancer and several initiatives pertaining to cancer research taken by major players are among the key driving factors for market growth.

Increasing investment in the field of oncology are among the factors expected to drive the oncology information system market over the forecast period. For instance, in 2018, Varian announced the acquisition of Noona Healthcare. Noona’s patient software application will help in capturing cancer patient-reported outcomes and facilitate direct communication with the patients. This acquisition will help Varian to boost its oncology software services. General Atlantic a Connecticut based company invested around USD 200 million for launching OneOncology, a company designed for helping community oncology practices with the technology data, innovation and research by leveraging the scale. Thus, these factors are expected to drive the OIS market growth.

Key players are also taking initiatives for developing more advanced OIS with an aim for bringing improvement in the cancer treatment. For instance, Elekta announced investment in PalabraApps LLC for the development of advanced Elekta Clinical workflow mobility and productivity tools. The tools developed through these investments will provide the customers with solutions, which are fully integrated with the Elekta's Mosaiq OIS for addressing the growing need of enhanced clinical efficiency and quality control. Such initiatives are anticipated to propel the oncology information system market during the forecast period.

For full research report on Oncology Information Systems Market visit here: https://www.grandviewresearch.com/industry-analysis/oncology-information-systems-market

Further key findings from the report suggest:

• In terms of revenue, software segment is estimated to expand at the highest CAGR over the forecast period, attributed to the benefits offered by software, such as streamlining and fine-tuning the patient management and data management processes
• Medical oncology is expected to register highest CAGR among application segment over the forecast period owing to the factors, such as increasing usage of chemotherapy, targeted therapy, and hormonal therapy
• Asia Pacific is expected to witness the fastest CAGR over the forecast period. Various government initiatives and increasing healthcare expenditure are anticipated to drive the regional growth
• Few key players operating in the oncology information systems market are Elekta AB, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories and Flatiron.

Get request sample of this report here: https://www.grandviewresearch.com/industry-analysis/oncology-information-systems-market/request/rs1

Grand View Research has segmented the global oncology information systems market on the basis of products and services, application, and region:

Oncology Information Systems Products and Services Outlook (Revenue, USD Billion, 2014 - 2026)

• Software
• Patient Information Systems
• Treatment Planning Systems
• Professional Services

Oncology Information Systems Application Outlook (Revenue USD Billion; 2014 - 2026)

• Medical Oncology
• Radiation Oncology
• Surgical Oncology

Oncology Information Systems Regional Outlook (Revenue, USD Billion; 2014 - 2026)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Asia-Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• MEA
• Saudi Arabia
• South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Hyperspectral Imaging Systems Market Size Is Predicted To Reach $17.64 Billion By 2025 | Industry Players Are Chemimage Corporation; and Applied Spectral imaging.

The global hyperspectral imaging systems market is anticipated to reach USD 17.64 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 10.6% during the forecast period. New product launches coupled with advancements in technology, designs, and features is driving the demand from various fields, such as military, remote sensing, healthcare, mining, vision and optical, and meteorology.

There are certain advantages of hyperspectral imaging, such as the non-requirement of prior knowledge of the spectrum and sample. In addition, it provides extensive information for analyzing and processing the image. These advantages are anticipated to drive investments from market players, which is anticipated to drive the demand during the forecast period. Hyperspectral imaging is being used extensively in the healthcare sector, mainly for ophthalmology, gastrointestinal procedures, tissue diagnosis, fluorescence microscopy, and vascular system imaging. The increasing application can be attributed mainly to its high clarity and accuracy of this imaging method.

Rapid industrialization along with demand for high bandwidth communication is fueling growth of hyperspectral imaging systems market in the forthcoming years. In addition, existing market players are switching to advanced technologies to gain competitive advantage. Rise in R&D and growth opportunities in emerging countries and the aim to maintain international product quality standards is anticipated to drive market expansion.

Affordable electronic circuits and high-speed technologies have cascaded into introduction of advanced sensor technologies. Furthermore, advancements in sensor technologies have improved the image quality, economic efficiency, and reliability of the technical products and thus, are anticipated to fuel the market growth.

For full research report on Hyperspectral Imaging Systems Market visit here: https://www.grandviewresearch.com/industry-analysis/hyperspectral-imaging-systems-market

Further key findings from the study suggest:

• Hyperspectral camera is estimated to hold the largest market share in near future due to the recent advancements in sensor development which have led to growth of the camera segment
• Military segment accounts for the largest market share due to advancement in data management of hyperspectral imaging along with component fabrication techniques, better accuracy and consistency compared to other conventional imaging techniques
• Asia Pacific has been estimated to be the fastest growing region due to the presence of large pool of patients, increasing healthcare awareness, rising government funding for R&D, and upcoming research projects
• Major players operating in the hyperspectral imaging systems market include Headwall Photonics Inc.; Resonon, Telops Inc.; Corning Incorporated; Norsk Elektro Optikk AS; Surface Optics Corporation; Bayspec Inc.; Chemimage Corporation; and Applied Spectral imaging.

Get request sample of this report here: https://www.grandviewresearch.com/industry-analysis/hyperspectral-imaging-systems-market/request/rs1

Grand View Research has segmented the global hyperspectral imaging systems market on the basis of product, application, and region:

Hyperspectral Imaging Systems Product Outlook (Revenue, USD Million, 2014 - 2025)

• Cameras
• Accessories

Hyperspectral Imaging Systems Application Outlook (Revenue, USD Million, 2014 - 2025)

• Military
• Remote Sensing
• Medical Diagnostics
• Machine Vision & Optical Sorting
• Others

Hyperspectral Imaging Systems Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Liver Cancer Diagnostic Market Size Is Estimated To Reach $15.4 Billion By 2025

The global liver cancer diagnostics market size is expected to reach USD 15.4 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 8.1% over the estimated time period. Rise in disease incidence coupled with growing demand for novel diagnosis products are thrusting the growth of the market. Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer in adults. It is among the common causes of death in people with liver cirrhosis and the third-leading cause of cancer deaths across the globe. Poor survival rate and lack of therapies has made this disease a crucial health issue worldwide.

Government and some global health organizations are undertaking initiatives to raise awareness regarding liver cancer through various campaigns. These programs aim to create awareness about signs, symptoms, and complications associated with carcinomas. High costs associated with cancer treatments compared to other diseases have led to increasingly rigid treatment guidelines for expensive drugs and diagnostic tests across various markets. For instance, the Affordable Care Act, designed to improve quality of healthcare and reduce the cost associated with it. This act covers reimbursement for cancer diagnosis and treatment up to a certain extent. Governments in other countries are also taking efforts to overcome challenges, such as cost and access to cancer care.

Such efforts and insurance policies that cover cost of diagnosis and treatment of carcinomas are supporting market growth. Newer techniques developed for hepatocellular carcinoma render both liver transplant, as well as surgical resection, more effective and safer. Several etiological factors of HCC such as hepatitis infection and cirrhosis are modifiable and thus present a strong prospect to reduce disease mortality by preventive strategies. Key players and medical institutions are focusing on the development of advanced tests for HCC diagnosis. These factors along with high unmet needs are expected to propel the growth of liver cancer diagnostics market through the forecast period.

For full research report on Liver Cancer Diagnostic Market visit here: https://www.grandviewresearch.com/industry-analysis/liver-cancer-diagnostic-market

Further key findings from the study suggest:

• Increasing awareness about liver cancer across the globe is expected to be the major factor driving the market growth
• Laboratory tests emerged as the largest segment owing to increased demand for effective diagnostic tests for HCC
• Oncofetal and Glucoprotein antigens accounted for the largest share in biomarkers segment
• North America led the global liver cancer diagnostic market in 2017 and will maintain the dominance in future on account of rising awareness about early diagnosis and demand for novel diagnostic tests in the region
• Illumina, Inc.; Qiagen; F. Hoffmann-La Roche Ltd.; Siemens Healthcare GmbH; and Thermo Fisher Scientific are some of the leading industry participants

Get request sample of this report here: https://www.grandviewresearch.com/industry-analysis/liver-cancer-diagnostic-market/request/rs1

Grand View Research has segmented the global liver cancer diagnostics market on the basis of screening type and region:

Liver Cancer Diagnostics Screening Type Outlook (Revenue, USD Million, 2014 - 2025)

• Laboratory Tests
• Biomarkers

• Oncofetal and Glycoprotein Antigens
• Enzymes and Isoenzymes
• Growth Factors and Receptors
• Molecular Markers
• Pathological Biomarkers
• Blood Tests
• Imaging
• Endoscopy
• Biopsy
• Others

Liver Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Metabolic Disorder Therapeutics Market Size To Reach $88.93 Billion By 2025 | Key Players Are Bristol-Myers Squibb Company; Cipla, Inc.; and CymaBay Therapeutics, Inc.

The global metabolic disorder therapeutics market size is expected to reach USD 88.93 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to witness a CAGR of 7.56% during the estimated period. Rising incidences of diabetes, obesity, and hypercholesterolemia are expected to drive the market growth. It is estimated that by 2040, about 1 person in 11 people worldwide is likely to suffer from one of the aforementioned diseases.

Researchers estimate that the prevalence of metabolic diseases like obesity and diabetes is expected to double in the coming 2 decades, mainly in U.S. and Asian and Latin American countries. This, in turn, will help boost the overall market growth in the year to come. Furthermore, with better economic stability in developing countries, demand for novel therapeutics for one-time treatment has increased. This has made major companies in the global market to invest heavily in R&D to develop innovative therapy options. All these factors will contribute to the development of the market.

For full research report on Metabolic Disorder Therapeutics Market visit here: https://www.grandviewresearch.com/industry-analysis/metabolic-disorder-therapeutics-market

Further key findings from the study suggest:

• Diabetes segment led the metabolic disorder therapeutics market in 2017, in terms of revenue generation,owing to higher prevalence and drug usage
• Obesity segment is expected to register a CAGR of 9.27% over the forecast period owing to increasing prevalence as a result of sedentary lifestyle changes
• Drug therapy was the most-preferred therapy due to its high reliability proven success and availability of various types of drugs to treat metabolic diseases
• The segment is expected to maintain its dominance even during the forecast years due to the introduction of smart technology to deliver antidiabetic drug on a regulated basis
• Key companies in this market are Novo Nordisk A/S;Sanofi S.A.; BoehringerIngelheim GmbH; Eli Lilly and Company; Merck KgaA; Amgen, Inc.; AstraZeneca PLC; Actelion Pharmaceuticals Ltd.; Shire PLC; AbbVie, Inc.;Biocon Ltd.;BioMarinPharmaceutical, Inc.; Bristol-Myers Squibb Company; Cipla, Inc.; and CymaBay Therapeutics, Inc.
• Most of these companies are focusing on strategies, such as collaborations, expansion of product portfolios, and M&A to maintain their industry position
• Oral route of administration was the key revenue-generating segment in 2017owing to its benefits, such as high reliability and ease of administration
• North America was the largest regional market in 2017 and will maintain the trend in future due to the presence of key companies and rising cases of diabetes and obesity

Get request sample of this report here: https://www.grandviewresearch.com/industry-analysis/metabolic-disorder-therapeutics-market/request/rs1

Grand View Research has segmented the global metabolic disorder therapeutics market on the basis of disease, therapy type, route of administration, and region:

Metabolic Disorder Therapeutics Disease Outlook (Revenue, USD Billion, 2014 - 2025)

• Lysosomal Storage Diseases
• Gaucher’s Disease
• Metachromatic Leukodystrophy
• Hurler - Scheie
• Sanfilipo A
• Others
• Diabetes
• Obesity
• Inherited Metabolic Disorders
• Hypercholesterolemia

Metabolic Disorder Therapy Type Outlook (Revenue, USD Billion, 2014 - 2025)

• Enzyme Replacement Therapy
• Cellular Transplantation
• Small Molecule Based Therapy
• Substrate Reduction Therapy
• Gene Therapy
• Drug Therapy

Metabolic Disorder Therapeutics Route of Administration Outlook (Revenue, USD Billion, 2014 - 2025)

• Oral
• Parenteral
• Others

Metabolic Disorder Therapeutics Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East & Africa
• South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

U.S. Hospital Consumables Market Players, Demand, Revenue, Features, Application, Opportunities, Share And Future Analysis 2025

The U.S. hospital consumables market size is anticipated to reach USD 53.24 billion by 2025, according to a new report by Grand View Research, Inc., experiencing a CAGR of 5.6% during the forecast period. Rising number of surgeries and prevalence of chronic diseases, coupled with expanding geriatric population in the U.S., is promoting the growth of the market.

Geriatric population in the U.S. accounts for a significant share in the overall population of the country. As per a report in 2018 by World Bank, the global population aged 60 years and above was 15.4% of the total population in 2017 in comparison with 12.9% in 2010. Aging makes a person more susceptible to cardiovascular, urological, and neurological diseases, among others. People suffering from these conditions often require surgical interventions. Thus, increasing elderly population is projected to provide an upthrust to the U.S. market.

Based on product, the segments reviewed in the report include medical gloves, medical gauze, disposable syringes, catheters, non-woven disposable products, glucometer strips, IV solutions, and general procedure trays. The non-woven medical disposables segment represented over 29.0% of the overall revenue in 2017. Non-woven disposables are either made from natural fibers, such as cotton and linen, or synthetic fibers such as polypropylene, polytetrafluoroethylene, and polyester. These fabrics protect patients and medical professionals from hospital-acquired infections (HAIs).

General procedure trays are poised to be the most promising product segment during the forecast period. These trays consist of specific tools and instruments used in surgical and diagnostic procedures related to cardiovascular, orthopedics, ophthalmic, and dental procedures, among others. Procedure kits can effectively reduce waste generation in hospitals. Moreover, custom kits can also reduce time required for specific surgeries, leading to a greater number of surgeries being performed in lesser time.

The U.S. hospital consumables market consists of a large number of players manufacturing several products. Some of the players operating in this space are McKesson Medical-Surgical Inc.; Medline Industries, Inc.; B. Braun Melsungen A.G.; Terumo Medical Corporation; Owens and Minor; Smith And Nephew, Inc.; Cardinal Health; and 3M.

For full research report on U.S. Hospital Consumables Market visit here: https://www.grandviewresearch.com/industry-analysis/us-hospital-consumables-market

Further Key Findings From the Report Suggest:

• Non-woven disposable products are likely to hold the largest revenue share in the U.S. hospital consumables market throughout the forecast horizon
• General procedure trays are expected to register a CAGR of 10.2% during the same period
• The catheters segment is estimated to command over 17.0% of the overall revenue by 2025.

Get request sample of this report here: https://www.grandviewresearch.com/industry-analysis/us-hospital-consumables-market/request/rs1

Grand View Research has segmented the U.S. hospital consumables market on the basis of product:

U.S. Hospital Consumables Product Outlook (Revenue, USD Million, 2014 - 2025)

• Medical Gloves
• I.V. Kits
• Medical Gauze
• Disposable Syringes
• Sharps Disposable Containers
• Catheters
• Non-woven Disposable Products
• Surgical Blades
• Medicine Cups
• Cannula
• Guidewires
• Thermometer
• Stethoscope
• Glucometer Strips
• I.V Solutions
• 50 ml
• 100 ml
• 250 ml
• 500 ml
• 1000 ml
• BP Monitors
• General Procedure Trays
• Laceration Trays

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com